Pathophysiology of Parkinson's disease
- PMID: 10349507
- DOI: 10.1016/S0753-3322(99)80076-6
Pathophysiology of Parkinson's disease
Abstract
Parkinson's disease is a progressive disease with selective dopaminergic neuronal loss. The pathophysiology is at present better understood with plurifactorial etiology, including genetic predisposition and environmental toxic factors. The mechanisms of cell death are based upon oxidative stress and apoptosis. The heterogeneity of dopaminergic neuronal loss leads to etiopathogenic clues. In the same way, the model of functional organization of basal ganglia circuitry gives a basis for further experimental and therapeutic research.
Similar articles
-
Interactions between environmental and genetic factors in the pathophysiology of Parkinson's disease.IUBMB Life. 2003 Jun;55(6):323-7. doi: 10.1080/1521654031000153058. IUBMB Life. 2003. PMID: 12938734 Review.
-
Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.Pharmacol Ther. 2007 Jun;114(3):327-44. doi: 10.1016/j.pharmthera.2007.04.001. Epub 2007 Apr 19. Pharmacol Ther. 2007. PMID: 17521740 Review.
-
Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity.J Clin Neurosci. 2009 May;16(5):620-5. doi: 10.1016/j.jocn.2008.08.020. Epub 2009 Mar 13. J Clin Neurosci. 2009. PMID: 19285870 Review.
-
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14. Neuroscience. 2006. PMID: 16533572
-
Pathogenesis of Parkinson's disease.Curr Opin Neurol Neurosurg. 1992 Jun;5(3):295-300. Curr Opin Neurol Neurosurg. 1992. PMID: 1623255 Review.
Cited by
-
ErbB4 activation inhibits MPP+-induced cell death in PC12-ErbB4 cells: involvement of PI3K and Erk signaling.J Mol Neurosci. 2006;29(3):257-67. doi: 10.1385/JMN:29:3:257. J Mol Neurosci. 2006. PMID: 17085783
-
Vitamin D and Neurological Diseases: An Endocrine View.Int J Mol Sci. 2017 Nov 21;18(11):2482. doi: 10.3390/ijms18112482. Int J Mol Sci. 2017. PMID: 29160835 Free PMC article. Review.
-
Parkinson's disease exacerbation following Levetiracetam administration: an unusual phenomenon.Oxf Med Case Reports. 2025 Jan 18;2025(1):omae174. doi: 10.1093/omcr/omae174. eCollection 2025 Jan. Oxf Med Case Reports. 2025. PMID: 39839697 Free PMC article.
-
Transforaminal Percutaneous Endoscopic Discectomy in Parkinson Disease: Preliminary Results and Short Review of the Literature.Korean J Spine. 2016 Sep;13(3):144-150. doi: 10.14245/kjs.2016.13.3.144. Epub 2016 Sep 30. Korean J Spine. 2016. PMID: 27799995 Free PMC article.
-
Vitamin D and neurodegenerative diseases.Heliyon. 2023 Jan 12;9(1):e12877. doi: 10.1016/j.heliyon.2023.e12877. eCollection 2023 Jan. Heliyon. 2023. PMID: 36820164 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical